IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sucampo Pharmaceuticals Inc

CUSIP: 864909AA4 | 47 institutional holders

Quarters

Q4 2017Q3 2017Q2 2017Q1 2017Q4 2016
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2017

Athyrium Capital Management, LP12,000,000
8.7% of portfolio›$14.7K
UBS Group AG3,500,000
0.0% of portfolio›$4.3K
Gabelli Funds LLC2,250,000
0.0% of portfolio›$2.7K
Worth Venture Partners, LLC1,878,000
0.1% of portfolio›$2.3K
StyleTurnoverLocationFiled
Athyrium Capital Management, LP
12,000,000$14.7K8.7%GARPVery HighNew York, NY2018-02-14
UBS Group AG
3,500,000$4.3K0.0%CoreMediumZurich, Switzerland2018-02-14
Gabelli Funds LLC
2,250,000$2.7K0.0%ValueLowRye, NY2018-02-02
Worth Venture Partners, LLC
1,878,000$2.3K0.1%YieldHighFort Lee, NJ2018-02-14